{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:22:50Z","timestamp":1792315370361,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T00:00:00Z","timestamp":1163116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1245\/s10434-006-9208-4","type":"journal-article","created":{"date-parts":[[2006,11,9]],"date-time":"2006-11-09T06:31:11Z","timestamp":1163053871000},"page":"795-801","source":"Crossref","is-referenced-by-count":11,"title":["Synergistic Antitumor Effects of Histamine Plus Melphalan in Isolated Hepatic Perfusion for Liver Metastases"],"prefix":"10.1245","volume":"14","author":[{"given":"Flavia","family":"Brunstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M. M.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela aan","family":"de Wiel-Ambagtsheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra T.","family":"van Tiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Rens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo L. M. ten","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,10]]},"reference":[{"key":"9208_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/lt.500050113","volume":"5","author":"MA Choti","year":"1999","unstructured":"Choti MA, Bulkley GB. Management of hepatic metastases. Liver Transpl Surg 1999; 5:65\u201380","journal-title":"Liver Transpl Surg"},{"key":"9208_CR2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1634\/theoncologist.9-6-653","volume":"9","author":"A Grover","year":"2004","unstructured":"Grover A, Alexander HR Jr. The past decade of experience with isolated hepatic perfusion. Oncologist 2004; 9:653\u2013664","journal-title":"Oncologist"},{"key":"9208_CR3","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.ejca.2004.04.009","volume":"40","author":"J Rothbarth","year":"2004","unstructured":"Rothbarth J, Tollenaar RA, Schellens JH, et al. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives. Eur J Cancer 2004; 40:1812\u20131824","journal-title":"Eur J Cancer"},{"key":"9208_CR4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjc.6600707","volume":"88","author":"B Etten van","year":"2003","unstructured":"van Etten B, de Vries MR, van Ijken MG, et al. Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion. Br J Cancer 2003; 88:314\u2013319","journal-title":"Br J Cancer"},{"key":"9208_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00002371-200007000-00008","volume":"23","author":"MG Ijken van","year":"2000","unstructured":"van Ijken MG, van Etten B, de Wilt JH, van Tiel ST, ten Hagen TL, Eggermont AM. Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model. J Immunother 2000; 23:449\u2013455","journal-title":"J Immunother"},{"key":"9208_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/sonc.2002.31681","volume":"29","author":"DM Weinreich","year":"2002","unstructured":"Weinreich DM, Alexander HR. Transarterial perfusion of liver metastases. Semin Oncol 2002; 29:136\u2013144","journal-title":"Semin Oncol"},{"key":"9208_CR7","first-page":"784","volume":"7","author":"TE Lans","year":"2001","unstructured":"Lans TE, Bartlett DL, Libutti SK, et al. Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion. Clin Cancer Res 2001; 7:784\u2013790","journal-title":"Clin Cancer Res"},{"key":"9208_CR8","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/jnci\/djh300","volume":"96","author":"F Brunstein","year":"2004","unstructured":"Brunstein F, Hoving S, Seynhaeve AL, et al. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies. J Natl Cancer Inst 2004; 96:1603\u20131610","journal-title":"J Natl Cancer Inst"},{"key":"9208_CR9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.bjc.6600089","volume":"86","author":"B Etten van","year":"2002","unstructured":"van Etten B, ten Hagen TL, de Vries MR, Ambagtsheer G, Huet T, Eggermont AM. Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras. Br J Cancer 2002; 86:436\u2013442","journal-title":"Br J Cancer"},{"key":"9208_CR10","first-page":"709","volume":"72","author":"WJ Kort","year":"1984","unstructured":"Kort WJ, Zondervan PE, Hulsman LO, Weijma IM, Westbroek DL. Incidence of spontaneous tumors in a group of retired breeder female brown Norway rats. J Natl Cancer Inst 1984; 72:709\u2013713","journal-title":"J Natl Cancer Inst"},{"key":"9208_CR11","first-page":"227","volume":"98","author":"TL Hagen","year":"2004","unstructured":"Hagen TL, Eggermont AM. Tumor vascular therapy with TNF: critical review on animal models. Methods Mol Med 2004; 98:227\u2013246","journal-title":"Methods Mol Med"},{"key":"9208_CR12","first-page":"1694","volume":"51","author":"LM Brauw de","year":"1991","unstructured":"de Brauw LM, Marinelli A, van de Velde CJ, Hermans J, Tjaden UR, Erkelens C, de Bruijn EA. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil. Cancer Res 1991; 51:1694\u20131700","journal-title":"Cancer Res"},{"key":"9208_CR13","first-page":"3993","volume":"61","author":"RK Ausman","year":"1961","unstructured":"Ausman RK. Development of a technique for isolated perfusion of the liver. N Y State J Med 1961; 61:3993\u20133997","journal-title":"N Y State J Med"},{"key":"9208_CR14","first-page":"1811","volume":"23","author":"MR Vries de","year":"2003","unstructured":"de Vries MR, ten Hagen TL, Marinelli AW, Eggermont AM. Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies. Anticancer Res 2003; 23:1811\u20131823","journal-title":"Anticancer Res"},{"key":"9208_CR15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0039-6109(03)00233-0","volume":"84","author":"JH Wilt de","year":"2004","unstructured":"de Wilt JH, van Etten B, Verhoef C, Eggermont AM. Isolated hepatic perfusion: experimental evidence and clinical utility. Surg Clin North Am 2004; 84:627\u2013641","journal-title":"Surg Clin North Am"},{"key":"9208_CR16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000658-199812000-00007","volume":"228","author":"MG Ijken van","year":"1998","unstructured":"van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM. Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs. Ann Surg 1998; 228:763\u2013770","journal-title":"Ann Surg"},{"key":"9208_CR17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1245\/ASO.2004.09.021","volume":"11","author":"B Etten van","year":"2004","unstructured":"van Etten B, Brunstein F, van Ijken MG, et al. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study. Ann Surg Oncol 2004; 11:598\u2013605","journal-title":"Ann Surg Oncol"},{"key":"9208_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-642-80460-1_11","volume":"147","author":"MR Vries de","year":"1998","unstructured":"de Vries MR, Borel RI, van de Velde CJ, et al. Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans. Recent Results Cancer Res 1998; 147:107\u2013119","journal-title":"Recent Results Cancer Res"},{"key":"9208_CR19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/bjc.1997.255","volume":"75","author":"PJ Kuppen","year":"1997","unstructured":"Kuppen PJ, Jonges LE, van de Velde CJ, Vahrmeijer AL, Tollenaar RA, Borel RI, Eggermont AM. Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion. Br J Cancer 1997; 75:1497\u20131500","journal-title":"Br J Cancer"},{"key":"9208_CR20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00262-004-0537-5","volume":"53","author":"SS Agarwala","year":"2004","unstructured":"Agarwala SS, Hellstrand K, Gehlsen K, Naredi P. Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis. Cancer Immunol Immunother 2004; 53:840\u2013841","journal-title":"Cancer Immunol Immunother"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-006-9208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-006-9208-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-006-9208-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T04:51:44Z","timestamp":1559623904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-006-9208-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,10]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["9208"],"URL":"https:\/\/doi.org\/10.1245\/s10434-006-9208-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,10]]}}}